Akụkọ
-
Akwụkwọ akụkọ Iwu ọhụrụ
1. A ga-amachibido iwu ndebanye aha FDA ọhụrụ maka ịchọ mma ịchọ mma US na-enweghị ndebanye aha FDA n'ịre ahịa. Dị ka iwu Modernization of Cosmetics Regulation Act nke 2022, nke Onye isi ala Biden bịanyere aka na ya na Disemba 29, 2022, ihe ịchọ mma niile ebupụ na United States ga-abụrịrị FDA-edeba aha...GỤKWUO -
2023 API 88th CHINA
Ozi gbasara JYMed na 2023 API CHINA 【on-saịtị】 N'okpuru nduzi nke Vice General Manager Zhi Qin, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọkarị JYMed) sonyere na ihe ngosi a dị ebube. JYMed gosipụtara ngwaahịa bara uru Semaglutide, Liraglutide, Tirzepatide, O ...GỤKWUO -
Nabata izute anyị na ihe ngosi API na ngwaahịa Qindao China JYMed: N4K32
GỤKWUO -
JYMed jikọtara gị na PCHi
Mgbe afọ abụọ nke atụmanya, 2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) ka emere na Guangzhou Canton Fair Complex na February 15-17, 2023. PCHi bụ ihe ngosi ahia ahia mba ofesi na-eje ozi ihe ịchọ mma zuru ụwa ọnụ, kwa ...GỤKWUO -
Semeglutide API nke Shenzhen JYMed nabatara nke mbụ ogbe nke anụ ụlọ NMPA na debara aha na US FDA (DMF No. 036009) na ọnọdụ "A".
Na Mee 2022, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọ JYMed peptide) nyefere ngwa maka ndebanye aha nke semaglutide API na US Food and Drug Administration (FDA) (nọmba ndebanye aha DMF: 036009), Ọ gafere nyocha iguzosi ike n'ezi ihe, na ọnọdụ ugbu a i...GỤKWUO
